Evidence map›Paper›PMID 34941662›Full record

ReviewTropical medicine and infectious disease2021

Active Case Finding for Tuberculosis in India: A Syntheses of Activities and Outcomes Reported by the National Tuberculosis Elimination Programme.

Sharath Burugina Nagaraja, Pruthu Thekkur, Srinath Satyanarayana, Prathap Tharyan, Karuna D Sagili, Jamhoih Tonsing, Raghuram Rao, Kuldeep Singh Sachdeva

Abstract readReview
In one paragraph

Review in Tropical medicine and infectious disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Assessing the TB Mukt Gram Panchayat Program in Rajasthan: A Way toward Tuberculosis Elimination.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sharath Burugina NagarajaDepartment of Community Medicine, Post Graduate Institute of Medical Sciences and Research, Employees State Insurance Corporation Medical College, Bengaluru 560010, India.ORCID 0000-0002-6599-5753
Pruthu ThekkurThe Union, South East Asia Office, New Delhi 110016, India.ORCID 0000-0001-5257-5074
Srinath SatyanarayanaThe Union, South East Asia Office, New Delhi 110016, India.ORCID 0000-0002-5420-2551
Prathap TharyanBV Moses Centre for Evidence-Informed Health Care, Clinical Epidemiological Unit, Christian Medical College, Vellore 632002, India.
Karuna D SagiliThe Union, South East Asia Office, New Delhi 110016, India.
Jamhoih TonsingThe Union, South East Asia Office, New Delhi 110016, India.
Raghuram RaoCentral TB Division, Ministry of Health and Family Welfare, New Delhi 110001, India.
Kuldeep Singh SachdevaThe Union, South East Asia Office, New Delhi 110016, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

India launched a national community-based active TB case finding (ACF) campaign in 2017 as part of the strategic plan of the National Tuberculosis Elimination Programme (NTEP). This review evaluated the outcomes for the components of the ACF campaign against the NTEP's minimum indicators and elicited the challenges faced in implementation. We supplemented data from completed pretested data proformas returned by ACF programme managers from nine states and two union territories (for 2017-2019) and five implementing partner agencies (2013-2020), with summary national data on the state-wise ACF outcomes for 2018-2020 published in annual reports by the NTEP. The data revealed variations in the strategies used to map and screen vulnerable populations and the diagnostic algorithms used across the states and union territories. National data were unavailable to assess whether the NTEP indicators for the minimum proportions identified with presumptive TB among those screened (5%), those with presumptive TB undergoing diagnostic tests (>95%), the minimum sputum smear positivity rate (2% to 3%), those with negative sputum smears tested with chest X-rays or CBNAAT (>95%) and those diagnosed through ACF initiated on anti-TB treatment (>95%) were fulfilled. Only 30% (10/33) of the states in 2018, 23% (7/31) in 2019 and 21% (7/34) in 2020 met the NTEP expectation that 5% of those tested through ACF would be diagnosed with TB (all forms). The number needed to screen to diagnose one person with TB (NNS) was not included among the NTEP's programme indicators. This rough indicator of the efficiency of ACF varied considerably across the states and union territories. The median NNS in 2018 was 2080 (interquartile range or IQR 517-4068). In 2019, the NNS was 2468 (IQR 1050-7924), and in 2020, the NNS was 906 (IQR 108-6550). The data consistently revealed that the states that tested a greater proportion of those screened during ACF and used chest X-rays or CBNAAT (or both) to diagnose TB had a higher diagnostic yield with a lower NNS. Many implementation challenges, related to health systems, healthcare provision and difficulties experienced by patients, were elicited. We suggest a series of strategic interventions addressing the implementation challenges and the six gaps identified in ACF outcomes and the expected indicators that could potentially improve the efficacy and effectiveness of community-based ACF in India.

Indexed as

active case findingdiagnostic algorithmnumber needed to screentuberculosis

Identifiers

PMID34941662
PMCPMC8705069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.